Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M33,254Revenue $M7,720Net Margin (%)11.1Altman Z-Score2.4
Enterprise Value $M41,527EPS $2.3Operating Margin %16.2Piotroski F-Score6
P/E(ttm)32.1Beneish M-Score-2.2Pre-tax Margin (%)11.2Higher ROA y-yY
Price/Book3.810-y EBITDA Growth Rate %12.4Quick Ratio1.0Cash flow > EarningsY
Price/Sales3.65-y EBITDA Growth Rate %8.3Current Ratio1.4Lower Leverage y-yY
Price/Free Cash Flow106y-y EBITDA Growth Rate %10.3ROA % (ttm)5.2Higher Current Ratio y-yN
Dividend Yield %--PEG3.9ROE % (ttm)19.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M490ROIC % (ttm)9.8Gross Margin Increase y-yY

Gurus Latest Trades with MYL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYLJoel Greenblatt 2015-03-31 Reduce-0.3%$52.74 - $64.96
($57.01)
$ 70.1223%Reduce 97.62%16,021
MYLVanguard Health Care Fund 2015-03-31 Add0.11%$52.74 - $64.96
($57.01)
$ 70.1223%Add 5.68%15,891,898
MYLFirst Eagle Investment 2015-03-31 Reduce-0.04%$52.74 - $64.96
($57.01)
$ 70.1223%Reduce 30.38%586,016
MYLJohn Paulson 2014-12-31 Add0.72%$46.5 - $58.62
($53.92)
$ 70.1230%Add 19.64%14,948,400
MYLJoel Greenblatt 2014-12-31 Buy 0.31%$46.5 - $58.62
($53.92)
$ 70.1230%New holding673,287
MYLVanguard Health Care Fund 2014-12-31 Reduce-0.05%$46.5 - $58.62
($53.83)
$ 70.1230%Reduce 2.64%15,037,080
MYLFirst Eagle Investment 2014-12-31 Add$46.5 - $58.62
($53.83)
$ 70.1230%Add 3.97%841,779
MYLVanguard Health Care Fund 2014-09-30 Add1.24%$44.97 - $52.34
($48.56)
$ 70.1244%Add 223.41%15,444,880
MYLFirst Eagle Investment 2014-09-30 Reduce-0.06%$44.97 - $52.34
($48.56)
$ 70.1244%Reduce 34.81%809,603
MYLMario Gabelli 2014-09-30 Reduce$44.97 - $52.34
($48.56)
$ 70.1244%Reduce 27.54%10,000
MYLFirst Eagle Investment 2014-06-30 Add0.07%$45.72 - $52.1
($49.11)
$ 70.1243%Add 83.88%1,241,991
MYLFirst Eagle Investment 2014-03-31 Buy 0.09%$42.26 - $57.2
($48.38)
$ 70.1245%New holding675,428
MYLJoel Greenblatt 2014-03-31 Sold Out -0.01%$42.26 - $57.2
($48.38)
$ 70.1245%Sold Out0
MYLDavid Dreman 2014-03-31 Sold Out $42.26 - $57.2
($48.38)
$ 70.1245%Sold Out0
MYLJoel Greenblatt 2013-12-31 Reduce$37.865 - $44.5
($41.09)
$ 70.1271%Reduce 31.83%7,291
MYLDavid Dreman 2013-12-31 Buy $37.865 - $44.5
($41.09)
$ 70.1271%New holding1,221
MYLJoel Greenblatt 2013-09-30 Reduce-0.16%$30.37 - $38.95
($35.23)
$ 70.1299%Reduce 91.73%10,695
MYLJohn Paulson 2013-06-30 Reduce-0.98%$27.96 - $31.87
($29.87)
$ 70.12135%Reduce 32.83%12,139,300
MYLJoel Greenblatt 2013-06-30 Add0.15%$27.96 - $31.87
($29.87)
$ 70.12135%Add 668.47%129,295
MYLVanguard Health Care Fund 2013-06-30 Add0.07%$27.96 - $31.87
($29.87)
$ 70.12135%Add 14.36%4,775,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MYL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HIGGINS MELINA EDirector 2015-06-15Sell8,351$73.08-4.05view
Cindrich Robert JDirector 2015-02-03Sell40,645$53.1531.93view
CAMERON WENDYDirector 2015-02-03Sell106,551$53.1531.93view
COURY ROBERT JExecutive Chairman 2015-02-03Sell947,119$52.5533.43view
Malik RajivPresident 2015-02-03Sell285,394$53.1531.93view
MAROON JOSEPH C MDDirector 2015-02-03Sell136,551$53.1531.93view
BRESCH HEATHER MCEO 2015-02-03Sell411,996$53.1531.93view
DIMICK NEIL FDirector 2015-02-03Sell19,781$53.1531.93view
Mauro AnthonyPresident, North America 2015-02-03Sell13,255$53.1531.93view
LEECH DOUGLAS JDirector 2015-02-03Sell62,271$53.1531.93view

Quarterly/Annual Reports about MYL:

    News about MYL:

    Articles On GuruFocus.com
    KEELEY All Cap Value Fund First Quarter 2015 Commentary Jun 17 2015 
    Actavis Stock – A Must Have For Long-Term Investors May 27 2015 
    Tom Russo Buys 3 New Stocks in Q1 May 18 2015 
    Teva Puts Forth Its Best Bid To Acquire Mylan Apr 25 2015 
    Teva Eyeing Mylan For $40 Billion Apr 23 2015 
    CalAmp and Illumina Significant Earnings Growth; Perrigo Rebuffs Takeover Offer Apr 22 2015 
    Vanguard Health Care Fund Comments on Mylan NV Mar 27 2015 
    Vanguard Health Care Fund 2014 Annual Report Mar 27 2015 
    Impax Laboratories Inc. Steps Into Profitable Zone Feb 26 2015 
    Gilead Taking Giant Leap To Serve The Hepatitis C Market Of Developing Countries Feb 26 2015 

    More From Other Websites
    [video]Mergers and Acquisitions Boom Will Keep Rolling as Interest Rates Rise Jul 02 2015
    Momenta Downgraded After Stock Price Doubles Jul 02 2015
    Top Takeaways From BMO's Specialty Pharma Day Jul 01 2015
    A New Rider in the Perrigo, Mylan, Teva Merger Merry-Go-Round Jun 30 2015
    EU regulators to rule on Mylan bid for Perrigo by July 29 Jun 25 2015
    Mylan eyes Tel Aviv listing if Perrigo deal goes ahead Jun 24 2015
    Perrigo Going Up With Or Without Mylan, Says BMO Jun 23 2015
    Mylan CFO to meet Tel Aviv bourse chief to discuss listing - source Jun 23 2015
    Question for FTC: Is Mylan based at Southpointe or in the Netherlands? Jun 22 2015
    Teva Announces Acquisition of 4.61% Interest in Mylan - Analyst Blog Jun 22 2015
    4 Top S&P 500 Stocks to Buy Not Domiciled in the US Jun 22 2015
    After Tax Inversion, Mylan Seeks Uncle Sam’s Aid in Teva Dispute Jun 19 2015
    Law Firm Reed Smith Names Steven Agnoli CIO Jun 19 2015
    Teva boosts stake in takeover target Mylan Jun 19 2015
    Nasdaq's new record by the numbers Jun 19 2015
    Teva gains standing to challenge Mylan poison pill Jun 19 2015
    Teva takes 4.6 percent stake in Mylan as part of bid Jun 19 2015
    Teva takes 4.6 percent stake in Mylan as part of bid Jun 19 2015
    Teva Completes the Purchase of 4.61 Percent Interest in Mylan N.V. Jun 19 2015
    Teva ups Mylan stake, handed setback in court ruling Jun 18 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK